Revr

Revr is a protein design engine built specifically for protein-based therapeutics. Instead of relying on trial-and-error in the lab, it uses AI to predict and generate protein sequences that are more likely to work as intended. The platform covers the full pipeline — from initial design through optimization to synthesis — so researchers can move faster from idea to candidate.

The engine stands out because it combines AI predictions with real biological constraints. It doesn't just generate sequences that look good on paper; it filters for stability, expression, and other factors that matter in actual cells. This grounding in biological reality means fewer failed experiments and a shorter path to viable drug candidates. The rapid optimization loop lets scientists iterate on designs in days rather than weeks.

Revr is aimed at drug discovery teams in pharmaceutical companies, biotech startups, and academic labs. It's most useful for anyone developing monoclonal antibodies, enzymes, or other protein-based drugs. Typical use cases include designing new therapeutic candidates, improving the stability of existing proteins, and accelerating the preclinical development cycle. The tool is still in pre-launch, with a signup form available for early access.